tirzepatide tachycardia Supraventricular (SVT) Tirzepatide's Association With BP Reduction

These factors indicate that GLP-1expressing probiotics remain a proof-of-concept technology with substantial risks and unresolved translational barriers

Corazza M, et al

Retrieved 12 June 2022

Instead, changes in libido are typically caused by the indirect consequences of taking the drug, such as significant weight loss, metabolic changes, and side effects

Whilst the research into GLP-1 receptor agonists and Parkinson's disease is promising, it remains in relatively early stages, and robust evidence from large-scale trials is needed before these drugs can be recommended for neuroprotection or symptom management in Parkinson's disease

doi: 10.1161/JAHA.116.005465 40 Nagy-SzakalDBarupalDLeeBCheXWilliamsBKahnEet al